1. Toda K, Kawada K, Iwamoto M, Inamoto S, Sasazuki T, Shirasawa S, Hasegawa S, Sakai Y. Metabolic Alterations Caused by KRAS Mutations in Colorectal Cancer Contribute to Cell Adaptation to Glutamine Depletion by Upregulation of Asparagine Synthetase. Neoplasia, 18(11):654-665, 2016
2. Ishikura S, Tsunoda T, Nakabayashi K, Doi K, Koyanagi M, Hayashi K, Kawai T, Tanaka Y, Iwaihara Y, Luo H, Nishi K, Okamura T, Shirasawa S. Molecular mechanisms of transcriptional regulation by the nuclear zinc-finger protein Zfat in T cells. Biochim Biophys Acta, 1859(11):1398-1410, 2016
3. Kotake Y, Naemura M, Kitagawa K, Niida H, Tsunoda T, Shirasawa S, Kitagawa M. Oncogenic Ras influences the expression of multiple lncRNAs. Cytotechnology, 68(4):1591-1596, 2016
4. Swain A, Kulkeaw K, Tanaka Y, Nakanishi Y, Shirasawa S, Sugiyama D. DBA lectin binds to highly proliferative mouse erythroleukemia cells. Anticancer Res, 36(7): 3625-3633, 2016
5. Luo H, Umebayashi M, Doi K, Morisaki T, Shirasawa S, Tsunoda T. Resveratrol overcomes cellular resistance to vemurafenib through dephosphorylation of AKT in BRAF-mutated melanoma cells. Anticancer Res, 36(7):3585-3589, 2016
6. Ishikura S, Iwaihara Y, Tanaka Y, Luo H, Nishi K, Doi K, Koyanagi M, Okamura T, Tsunoda T, Shirasawa S. The nuclear zinc finger protein Zfat maintains FoxO1 protein levels in peripheral T cells by regulating activities of autophagy and Akt signaling pathway. J Biol Chem, 291(29):15282-15291, 2016
7. Bordonaro M, Shirasawa S, Lazarova DL. In hyperthermia increased ERK and WNT signaling suppress colorectal cancer cell growth. Cancers (Basel), 8(5) pii:E49, 2016 doi: 10.3390/cancers8050049
8. Goulielmaki M, Koustas E, Moysidou E, Vlassi M, Sasazuki T, Shirasawa S, Zografos G, Oikonomou E, Pintzas A. BRAF associated autophagy exploitation: BRAF and autophagy inhibitors synergise to efficiently overcome resistance of BRAF mutant colorectal cancer cells. Oncotarget, 7(8):9188-9221, 2016
9. Naemura M, Tsunoda T, Inoue Y, Okamoto H, Shirasawa S, Kotake Y. ANRIL regulates the proliferation of human colorectal cancer cells in both two- and three-dimensional culture. Mol Cell Biochem, 412(1-2):141-146, 2016
10. Lapa GB, Tsunoda T, Shirasawa S, Baryshnikova MA, Evseev GG, Afanasyeva DA, Chigorina EA. Synthesis of new congeners of 1-methyl-3-aminoisoquinolines, evaluation of their cytotoxic activity, in silico and in vitro study of their molecular targets as PDE4B. Chem Biol Drug Des, 87(4):575-582, 2016
11. Dunne PD, Dasgupta S, Blayney J, McArt DG, Redmond KL, Weir JA, Bradley CA, Sasazuki T, Shirasawa S, Wang T, Srivastava S, Ong CW, Arthur K, Salto-Tellez M, Wilson RH, Johnston PG, Van Schaeybroeck S. EphA2 expression is a key driver of migration and invasion and a poor prognostic marker in colorectal cancer. Clin Cancer Res, 22(1):230-242, 2016
2. Ishikura S, Tsunoda T, Nakabayashi K, Doi K, Koyanagi M, Hayashi K, Kawai T, Tanaka Y, Iwaihara Y, Luo H, Nishi K, Okamura T, Shirasawa S. Molecular mechanisms of transcriptional regulation by the nuclear zinc-finger protein Zfat in T cells. Biochim Biophys Acta, 1859(11):1398-1410, 2016
3. Kotake Y, Naemura M, Kitagawa K, Niida H, Tsunoda T, Shirasawa S, Kitagawa M. Oncogenic Ras influences the expression of multiple lncRNAs. Cytotechnology, 68(4):1591-1596, 2016
4. Swain A, Kulkeaw K, Tanaka Y, Nakanishi Y, Shirasawa S, Sugiyama D. DBA lectin binds to highly proliferative mouse erythroleukemia cells. Anticancer Res, 36(7): 3625-3633, 2016
5. Luo H, Umebayashi M, Doi K, Morisaki T, Shirasawa S, Tsunoda T. Resveratrol overcomes cellular resistance to vemurafenib through dephosphorylation of AKT in BRAF-mutated melanoma cells. Anticancer Res, 36(7):3585-3589, 2016
6. Ishikura S, Iwaihara Y, Tanaka Y, Luo H, Nishi K, Doi K, Koyanagi M, Okamura T, Tsunoda T, Shirasawa S. The nuclear zinc finger protein Zfat maintains FoxO1 protein levels in peripheral T cells by regulating activities of autophagy and Akt signaling pathway. J Biol Chem, 291(29):15282-15291, 2016
7. Bordonaro M, Shirasawa S, Lazarova DL. In hyperthermia increased ERK and WNT signaling suppress colorectal cancer cell growth. Cancers (Basel), 8(5) pii:E49, 2016 doi: 10.3390/cancers8050049
8. Goulielmaki M, Koustas E, Moysidou E, Vlassi M, Sasazuki T, Shirasawa S, Zografos G, Oikonomou E, Pintzas A. BRAF associated autophagy exploitation: BRAF and autophagy inhibitors synergise to efficiently overcome resistance of BRAF mutant colorectal cancer cells. Oncotarget, 7(8):9188-9221, 2016
9. Naemura M, Tsunoda T, Inoue Y, Okamoto H, Shirasawa S, Kotake Y. ANRIL regulates the proliferation of human colorectal cancer cells in both two- and three-dimensional culture. Mol Cell Biochem, 412(1-2):141-146, 2016
10. Lapa GB, Tsunoda T, Shirasawa S, Baryshnikova MA, Evseev GG, Afanasyeva DA, Chigorina EA. Synthesis of new congeners of 1-methyl-3-aminoisoquinolines, evaluation of their cytotoxic activity, in silico and in vitro study of their molecular targets as PDE4B. Chem Biol Drug Des, 87(4):575-582, 2016
11. Dunne PD, Dasgupta S, Blayney J, McArt DG, Redmond KL, Weir JA, Bradley CA, Sasazuki T, Shirasawa S, Wang T, Srivastava S, Ong CW, Arthur K, Salto-Tellez M, Wilson RH, Johnston PG, Van Schaeybroeck S. EphA2 expression is a key driver of migration and invasion and a poor prognostic marker in colorectal cancer. Clin Cancer Res, 22(1):230-242, 2016